510(k) approval for General Surgical Innovations:
This article was originally published in Clinica
Executive Summary
General Surgical Innovations' range of Spacemaker tissue dissection products has received 510(k) approval for its extended use which will include surgical use involving access to the spine and long-bone plating. Other applications are thoracoscopic procedures involving exposure and dissection of nerves, blood vessels and other tissues of the chest walls. The device produce surgical working space by separating natural tissue planes without the need to use blunt dissection as in conventional open surgery.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.